Vi­iV and Gilead hit im­passe in HIV ad­ver­tis­ing dis­pute, me­di­a­tor sends case to feds for re­view

Gilead Sci­ences and Vi­iV Health­care are locked in a stand­off over HIV ad­ver­tis­ing claims, and the pre­vail­ing ad in­dus­try me­di­at­ing or­ga­ni­za­tion is clos­ing its case …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER